New Releases from NCBI BookshelfPembrolizumab with carboplatin and paclitaxel for untreated primary advanced or recurrent endometrial cancer.Pembrolizumab with carboplatin and paclitaxel for untreated primary advanced or recurrent endometrial cancer.
Post Content
